Lawrence H Boise

32PUBLICATIONS
204CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Microelectromechanical systems (MEMS)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jan 15, 2026
Multimodal antigenic escape to GPRC5D-targeted T cell engagers in multiple myeloma.

Holly Lee, Sungwoo Ahn, Gerone A Gonzales

|Jan 02, 2026
Genomic mechanisms of resistance to venetoclax in multiple myeloma with t(11;14)(CCND1;IGH).

Marcella Kaddoura, J Erin Wiedmeier-Nutor, Vikas A Gupta

|Oct 17, 2025
ID2 Suppresses Multiple Myeloma Cell Proliferation by Repressing the Activity of the Transcription Factor TCF3.

Mariateresa Fulciniti, Yao Yao, Tommaso Perini

|May 13, 2025
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells.

Corynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar

|Jan 30, 2025
Targeting ABCD1-ACOX1-MET/IGF1R axis suppresses multiple myeloma.

Zhannan Han, Zhibo Yan, Zhehan Ma

Pageof 6